147 related articles for article (PubMed ID: 28569236)
1. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Rhinol (Providence); 2010 Apr; 1(2):14. PubMed ID: 28569236
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Asthma Proc; 2010; 31(2):132-40. PubMed ID: 20302683
[TBL] [Abstract][Full Text] [Related]
3. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
4. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
Lieberman P; Meltzer EO; LaForce CF; Darter AL; Tort MJ
Allergy Asthma Proc; 2011; 32(2):151-8. PubMed ID: 21352639
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
[TBL] [Abstract][Full Text] [Related]
7. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
Kaliner MA; Storms W; Tilles S; Spector S; Tan R; LaForce C; Lanier BQ; Chipps B
Allergy Asthma Proc; 2009; 30(3):255-62. PubMed ID: 19549426
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
Berger WE; Ratner PH; Casale TB; Meltzer EO; Wall GM
Allergy Asthma Proc; 2009; 30(6):612-23. PubMed ID: 20031007
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
Ratner PH; Hampel FC; Amar NJ; van Bavel JH; Mohar D; Marple BF; Roland PS; Wall GM; Brubaker MJ; Drake M; Turner D; Silver LH
Ann Allergy Asthma Immunol; 2005 Nov; 95(5):474-9. PubMed ID: 16312171
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis.
Bousquet J; Klimek L; Kuhl HC; Nguyen DT; Ramalingam RK; Canonica GW; Berger WE
Front Allergy; 2023; 4():1244012. PubMed ID: 37920410
[TBL] [Abstract][Full Text] [Related]
11. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
[No Abstract] [Full Text] [Related]
12. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
[TBL] [Abstract][Full Text] [Related]
14. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
Patel D; Garadi R; Brubaker M; Conroy JP; Kaji Y; Crenshaw K; Whitling A; Wall GM
Allergy Asthma Proc; 2007; 28(5):592-9. PubMed ID: 18034980
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis.
Andrews CP; Mohar D; Salhi Y; Tantry SK
Ann Allergy Asthma Immunol; 2020 Feb; 124(2):171-178.e2. PubMed ID: 31734334
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
Meltzer EO; Garadi R; Laforce C; Chadwick SJ; Berger WE; Gross G; Edwards MR; Crenshaw K; Wall GM
Allergy Asthma Proc; 2008; 29(6):659-68. PubMed ID: 19144261
[TBL] [Abstract][Full Text] [Related]
19. Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
Fifer S; Toh L; Barkate H; Aggarwal V; Borade D; Gordonsmith RH; Wu W; Morgan C; Young K
Patient Prefer Adherence; 2023; 17():141-151. PubMed ID: 36687019
[TBL] [Abstract][Full Text] [Related]
20. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
